148 related articles for article (PubMed ID: 8876881)
1. Preoperative radiotherapy for rectal cancer: benefits and controversies.
Ota DM
Ann Surg Oncol; 1996 Sep; 3(5):419-20. PubMed ID: 8876881
[No Abstract] [Full Text] [Related]
2. [Rectal cancer: treatment and results].
Luna Pérez P
Rev Invest Clin; 2001; 53(1):65-76. PubMed ID: 11332053
[No Abstract] [Full Text] [Related]
3. Adjuvant postoperative 5-fluorouracil chemotherapy combined with pelvic radiation for rectal cancer: results from an Asian population.
Au E; Koo WH; Lee KS; Chua EJ; Soo KC; Seow-Choen F; Low CH; Ng BK; Hoe M
Cancer Invest; 2001; 19(4):340-5. PubMed ID: 11405173
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.
Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E
Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant therapy of rectal cancer].
Bouaouina N; Boussen H
Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma].
Carau B; Orrù P; Orrù S; Dessì M; Nagliati M; Lay G; Maxia V; Casula G; Amichetti M
Tumori; 2003; 89(4 Suppl):7-8. PubMed ID: 12903531
[TBL] [Abstract][Full Text] [Related]
7. Month-long postoperative radiotherapy and 5-FU improve survival in rectal cancer.
Oncology (Williston Park); 1996 Sep; 10(9):1311. PubMed ID: 8882923
[No Abstract] [Full Text] [Related]
8. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
Allen DC; Fon LJ; McAleer JJ; Irwin ST
Ulster Med J; 1999 May; 68(1):17-21. PubMed ID: 10489807
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy and rectal cancer].
Michel P; Di Fiore F
Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
[TBL] [Abstract][Full Text] [Related]
10. [Cyto-reduction of rectal cancer after preoperative chemoradiotherapy].
Sánchez Maldonado W; Rodríguez Coria D; Luna Pérez P
Rev Gastroenterol Mex; 1995; 60(3):158. PubMed ID: 7481450
[No Abstract] [Full Text] [Related]
11. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
Janjan NA; Abbruzzese J; Pazdur R; Khoo VS; Cleary K; Dubrow R; Ajani J; Rich TA; Goswitz MS; Evetts PA; Allen PK; Lynch PM; Skibber JM
Radiother Oncol; 1999 May; 51(2):153-60. PubMed ID: 10435807
[TBL] [Abstract][Full Text] [Related]
12. Preoperative combined radiotherapy and chemotherapy for rectal cancer does not affect early postoperative morbidity and mortality in low anterior resection.
Pucciarelli S; Toppan P; Friso ML; Fornasiero A; Vieceli G; Marchiori E; Lise M
Dis Colon Rectum; 1999 Oct; 42(10):1276-83; discussion 1283-4. PubMed ID: 10528764
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant radiochemotherapy for rectal cancer].
Zehentmayr F; Wolf M; Weissenborn Y; Feldmann HJ; Belka C
MMW Fortschr Med; 2011 Sep; 153(35):31-3. PubMed ID: 21916302
[No Abstract] [Full Text] [Related]
14. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
15. [Choice of treatment in rectal cancer. Consensus Conference, Chamber of Commerce and Industry, Paris, December 1-2, 1994].
Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):226-30, 233-6. PubMed ID: 7486820
[No Abstract] [Full Text] [Related]
16. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
[TBL] [Abstract][Full Text] [Related]
17. [Therapy results of locoregional recurrences in rectal cancer].
Böhm B; Helfritzsch H; Thiele M; Altendorf-Hofmann A; Scheele J
Zentralbl Chir; 2001 Aug; 126(8):596-601. PubMed ID: 11518998
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
20. Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer.
Kaminski A; Joseph D; Elsaleh H
Australas Radiol; 2007 Jun; 51(3):283-8. PubMed ID: 17504322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
